Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Sponsor:Internal Funding
Enrolling:Male and Female Patients
Minimum Age:18 years old
IRB Number:AAAS0279
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information:

The purpose of the study is to evaluate the tolerability of a ketogenic diet in conjunction with metformin in people with malignant glioma. The study doctors will try to determine if maintaining the ketogenic diet with metformin will have any effect on your tumor.

Do You Qualify?
Are you 18 years of age or older?YesNo
Have you been diagnosed with high-grade glioma?YesNo
Are you receiving any other investigational drugs?YesNo
Submit
Cancel
Investigator
Andrew Lassman, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Research Nurse Navigator
Email: cancerclinicaltrials@cumc.columbia.edu
Phone: 212-342-5162